Annual EBITDA:
$69.95M+$77.65M(+1008.05%)Summary
- As of today, TMDX annual EBITDA is $69.95 million, with the most recent change of +$77.65 million (+1008.05%) on December 31, 2024.
- During the last 3 years, TMDX annual EBITDA has risen by +$108.44 million (+281.74%).
- TMDX annual EBITDA is now at all-time high.
Performance
TMDX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$43.30M+$9.72M(+28.94%)Summary
- As of today, TMDX quarterly EBITDA is $43.30 million, with the most recent change of +$9.72 million (+28.94%) on June 30, 2025.
- Over the past year, TMDX quarterly EBITDA has increased by +$26.19 million (+153.10%).
- TMDX quarterly EBITDA is now at all-time high.
Performance
TMDX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$100.30M+$26.19M(+35.34%)Summary
- As of today, TMDX TTM EBITDA is $100.30 million, with the most recent change of +$26.19 million (+35.34%) on June 30, 2025.
- Over the past year, TMDX TTM EBITDA has increased by +$59.29 million (+144.59%).
- TMDX TTM EBITDA is now at all-time high.
Performance
TMDX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TMDX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +1008.0% | +153.1% | +144.6% |
| 3Y3 Years | +281.7% | +593.4% | +358.8% |
| 5Y5 Years | +350.4% | +678.3% | +462.4% |
TMDX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +281.7% | at high | +915.6% | at high | +413.8% |
| 5Y | 5-Year | at high | +281.7% | at high | +484.2% | at high | +354.6% |
| All-Time | All-Time | at high | +281.7% | at high | +484.2% | at high | +354.6% |
TMDX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $43.30M(+28.9%) | $100.30M(+35.3%) |
| Mar 2025 | - | $33.58M(+134.4%) | $74.11M(+29.2%) |
| Dec 2024 | $69.95M(+1008.0%) | $14.32M(+57.4%) | $57.35M(+16.2%) |
| Sep 2024 | - | $9.10M(-46.8%) | $49.34M(+20.3%) |
| Jun 2024 | - | $17.11M(+1.7%) | $41.01M(+66.6%) |
| Mar 2024 | - | $16.82M(+166.7%) | $24.62M(+242.6%) |
| Dec 2023 | -$7.70M(+73.4%) | $6.31M(+719.2%) | $7.18M(+262.1%) |
| Sep 2023 | - | $770.00K(+7.2%) | -$4.43M(+54.2%) |
| Jun 2023 | - | $718.00K(+217.5%) | -$9.68M(+49.5%) |
| Mar 2023 | - | -$611.00K(+88.5%) | -$19.17M(+29.6%) |
| Dec 2022 | -$28.96M(+24.8%) | -$5.31M(-18.7%) | -$27.24M(+14.8%) |
| Sep 2022 | - | -$4.47M(+49.0%) | -$31.97M(+17.5%) |
| Jun 2022 | - | -$8.78M(-1.1%) | -$38.76M(+1.6%) |
| Mar 2022 | - | -$8.68M(+13.4%) | -$39.40M(-7.1%) |
| Dec 2021 | -$38.49M | -$10.03M(+11.0%) | -$36.78M(-14.2%) |
| Sep 2021 | - | -$11.27M(-19.7%) | -$32.22M(-28.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$9.42M(-55.3%) | -$25.15M(-8.3%) |
| Mar 2021 | - | -$6.06M(-10.9%) | -$23.22M(+6.4%) |
| Dec 2020 | -$23.15M(+17.1%) | -$5.47M(-29.9%) | -$24.81M(+10.4%) |
| Sep 2020 | - | -$4.21M(+43.8%) | -$27.68M(+8.9%) |
| Jun 2020 | - | -$7.49M(+2.1%) | -$30.38M(-0.2%) |
| Mar 2020 | - | -$7.65M(+8.3%) | -$30.31M(-6.8%) |
| Dec 2019 | -$27.93M(-38.1%) | -$8.34M(-20.7%) | -$28.38M(-8.4%) |
| Sep 2019 | - | -$6.91M(+6.8%) | -$26.18M(-13.8%) |
| Jun 2019 | - | -$7.42M(-29.7%) | -$23.00M(-47.6%) |
| Mar 2019 | - | -$5.72M(+6.9%) | -$15.59M(-57.9%) |
| Dec 2018 | -$20.23M(-6.0%) | -$6.14M(-64.8%) | -$9.87M(-22.4%) |
| Sep 2018 | - | -$3.73M(+14.1%) | -$8.06M(+9.3%) |
| Dec 2017 | -$19.09M(+15.8%) | - | - |
| Dec 2017 | - | -$4.34M(+4.7%) | -$8.89M(-95.3%) |
| Sep 2017 | - | -$4.55M | -$4.55M |
| Dec 2016 | -$22.66M | - | - |
FAQ
- What is TransMedics Group, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for TransMedics Group, Inc.?
- What is TransMedics Group, Inc. annual EBITDA year-on-year change?
- What is TransMedics Group, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for TransMedics Group, Inc.?
- What is TransMedics Group, Inc. quarterly EBITDA year-on-year change?
- What is TransMedics Group, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for TransMedics Group, Inc.?
- What is TransMedics Group, Inc. TTM EBITDA year-on-year change?
What is TransMedics Group, Inc. annual EBITDA?
The current annual EBITDA of TMDX is $69.95M
What is the all-time high annual EBITDA for TransMedics Group, Inc.?
TransMedics Group, Inc. all-time high annual EBITDA is $69.95M
What is TransMedics Group, Inc. annual EBITDA year-on-year change?
Over the past year, TMDX annual EBITDA has changed by +$77.65M (+1008.05%)
What is TransMedics Group, Inc. quarterly EBITDA?
The current quarterly EBITDA of TMDX is $43.30M
What is the all-time high quarterly EBITDA for TransMedics Group, Inc.?
TransMedics Group, Inc. all-time high quarterly EBITDA is $43.30M
What is TransMedics Group, Inc. quarterly EBITDA year-on-year change?
Over the past year, TMDX quarterly EBITDA has changed by +$26.19M (+153.10%)
What is TransMedics Group, Inc. TTM EBITDA?
The current TTM EBITDA of TMDX is $100.30M
What is the all-time high TTM EBITDA for TransMedics Group, Inc.?
TransMedics Group, Inc. all-time high TTM EBITDA is $100.30M
What is TransMedics Group, Inc. TTM EBITDA year-on-year change?
Over the past year, TMDX TTM EBITDA has changed by +$59.29M (+144.59%)